Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,602 | 1,298 | 99.7% |
| Education | $55.11 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $3,801 | 255 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,333 | 159 | $0 (2024) |
| Janssen Biotech, Inc. | $2,321 | 149 | $0 (2024) |
| ABBVIE INC. | $2,082 | 124 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,105 | 68 | $0 (2024) |
| PFIZER INC. | $927.58 | 54 | $0 (2024) |
| Horizon Pharma plc | $742.52 | 64 | $0 (2018) |
| Mallinckrodt Hospital Products Inc. | $625.41 | 37 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $599.85 | 31 | $0 (2024) |
| Genentech USA, Inc. | $470.06 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,337 | 119 | Janssen Biotech, Inc. ($443.88) |
| 2023 | $2,082 | 106 | Janssen Biotech, Inc. ($386.13) |
| 2022 | $2,158 | 115 | ABBVIE INC. ($413.65) |
| 2021 | $2,292 | 131 | Amgen Inc. ($408.37) |
| 2020 | $2,287 | 147 | Amgen Inc. ($658.61) |
| 2019 | $3,394 | 219 | Amgen Inc. ($777.48) |
| 2018 | $3,402 | 244 | Amgen Inc. ($586.69) |
| 2017 | $2,706 | 220 | Novartis Pharmaceuticals Corporation ($377.63) |
All Payment Transactions
1,301 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $33.93 | General |
| Category: Dermatology | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.07 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Inflammation | ||||||
| 10/04/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Dermatology | ||||||
| 09/21/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: Endocrinology | ||||||
| 09/18/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $37.38 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 355 | 488 | $72,300 | $38,414 |
| 2022 | 10 | 392 | 545 | $76,065 | $41,900 |
| 2021 | 11 | 411 | 590 | $93,625 | $52,655 |
| 2020 | 12 | 464 | 649 | $96,230 | $48,949 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 74 | 132 | $33,000 | $18,870 | 57.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 46 | 97 | $14,550 | $6,631 | 45.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 58 | 58 | $4,930 | $4,172 | 84.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 19 | 30 | $6,000 | $2,872 | 47.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 60 | 60 | $2,245 | $1,931 | 86.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 21 | $4,200 | $1,733 | 41.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 34 | 42 | $4,200 | $1,106 | 26.3% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 19 | 22 | $2,200 | $803.08 | 36.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $650.00 | $157.56 | 24.2% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 13 | 13 | $325.00 | $138.84 | 42.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 71 | 117 | $29,250 | $17,067 | 58.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 66 | 151 | $22,700 | $10,296 | 45.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 72 | 72 | $5,400 | $4,935 | 91.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 22 | 31 | $6,200 | $3,133 | 50.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 74 | 74 | $2,590 | $2,303 | 88.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 18 | $3,600 | $1,823 | 50.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 27 | 34 | $3,400 | $1,517 | 44.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 14 | 18 | $1,800 | $488.55 | 27.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 15 | $750.00 | $179.94 | 24.0% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2022 | 14 | 15 | $375.00 | $157.90 | 42.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 91 | 231 | $57,750 | $33,477 | 58.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 54 | $10,500 | $4,973 | 47.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 70 | 70 | $4,900 | $4,568 | 93.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 32 | 47 | $6,830 | $3,389 | 49.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 18 | 18 | $3,075 | $2,504 | 81.4% |
About Dr. Philip Poor, M.D
Dr. Philip Poor, M.D is a Internal Medicine healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013022433.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philip Poor, M.D has received a total of $20,657 in payments from pharmaceutical and medical device companies, with $2,337 received in 2024. These payments were reported across 1,301 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($20,602).
As a Medicare-enrolled provider, Poor has provided services to 1,622 Medicare beneficiaries, totaling 2,272 services with total Medicare billing of $181,919. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Sacramento, CA
- Active Since 08/19/2006
- Last Updated 07/17/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013022433
Products in Payments
- Enbrel (Biological) $3,414
- COSENTYX (Biological) $1,740
- TREMFYA (Drug) $1,240
- RINVOQ (Biological) $1,231
- BENLYSTA (Biological) $1,079
- ACTHAR (Biological) $1,063
- XELJANZ (Drug) $716.73
- COSENTYX (Drug) $562.93
- RAYOS (Drug) $463.27
- Humira (Biological) $418.56
- REMICADE (Biological) $414.16
- Rasuvo (Drug) $407.89
- OFEV (Drug) $395.03
- IDACIO (Biological) $387.05
- SIMPONI ARIA (Biological) $363.91
- Cimzia (Drug) $335.58
- KRYSTEXXA (Drug) $308.11
- STELARA (Biological) $302.61
- PENNSAID (Drug) $255.21
- Tymlos (Biological) $248.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sacramento
Dr. Samuel Louie, M.d, M.D
Internal Medicine — Payments: $3.0M
Dr. Christian Sandrock, Md, MD
Internal Medicine — Payments: $2.3M
Thomas Smith, M.d, M.D
Internal Medicine — Payments: $1.0M
Arash Aryana, M.d, M.D
Internal Medicine — Payments: $588,584
Dr. Jonathan Riess, M.d., M.s, M.D., M.S
Internal Medicine — Payments: $191,089
Dr. Ken Yoneda, Md, MD
Internal Medicine — Payments: $183,967